Eli Lilly and Company (LLY)
-NYSE 54.71 
0.43(0.78%) 3:41PM EDT - Nasdaq Real Time Price
| Prev Close: | 55.14 |
|---|
| Open: | 55.26 |
|---|
| Bid: | 54.79 x 200 |
|---|
| Ask: | 54.80 x 1300 |
|---|
| 1y Target Est: | 56.41 |
|---|
| Beta: | 0.42 |
|---|
| Next Earnings Date: | 24-Jul-13 |
|---|
| Day's Range: | 54.66 - 56.06 |
|---|
| 52wk Range: | 39.93 - 58.40 |
|---|
| Volume: | 3,593,419 |
|---|
| Avg Vol (3m): | 5,107,680 |
|---|
| Market Cap: | 59.31B |
|---|
| P/E (ttm): | 13.17 |
|---|
| EPS (ttm): | 4.16 |
|---|
| Div & Yield: | 1.96 (3.50%) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- The 5 Highest-Paying Dividend Stocks in Big Pharmaat Motley Fool(Wed 11:06AM EDT)
- 6 Ways You Can Profit From Molecular Diagnosticsat Seeking Alpha(Wed 10:00AM EDT)
- Do Major Drug Manufacturers Have Room to Grow?at Motley Fool(Wed 9:22AM EDT)
- Pricing A Highly Probable Takeover Of MannKindat Seeking Alpha(Wed 5:28AM EDT)
- The Surprising Link Between ADHD and Obesityat Motley Fool(Tue, May 21)
- Novartis Ramping Up Alzheimer’s Pursuit as Rivals’ Drugs Failat Bloomberg(Tue, May 21)
- The Top 3 Diseases Caused by Stressat Motley Fool(Tue, May 21)
- Eli Lilly And Company Stock Buy Recommendation Reiterated (LLY)at TheStreet(Tue, May 21)
- ‘Love Hormone’ Promises Safer Births After Pfizer Flopat Bloomberg(Mon, May 20)
- Big Pharma's Biggest Grudge Matchat Motley Fool(Mon, May 20)
- Vitamins That Cost Pennies a Day Seen Delaying Dementiaat Bloomberg(Mon, May 20)
- From Research Labs to Doctors' Offices, Health Care Providers at Lilly Play Important Role in Bringing New and Innovative Medicines to PatientsPR Newswire(Mon, May 20)
- 1 Great Dividend You Can Buy Right Nowat Motley Fool(Sun, May 19)
- One Year After The IPO, Is Facebook Already Becoming A New Economy Dog?at Forbes(Sun, May 19)
- Lundbeck-Takeda Drug Fights Depression Better at Higher Doseat Bloomberg(Sat, May 18)
Key Statistics
| Forward P/E (1 yr): | 20.07 |
|---|
| P/S (ttm): | 2.64 |
|---|
| Ex-Dividend Date: | 14-May-13 |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 3.91 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 1.00 |
|---|
| Mean Recommendation*: | 2.6 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products worldwide. The companys neuroscience products treat major depressive disorders; schizophrenia, acute mixed or manic episodes associated with bipolar I...
View More